Gundaya, Nila G.

HRN: 22-16-07  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/09/2022
CEFUROXIME 1.5GM (VIAL)
12/10/2022
12/10/2022
IV
1.5
On Call To OR
For THBSO
Waiting Final Action 
12/10/2022
CEFUROXIME 1.5GM (VIAL)
12/10/2022
12/12/2022
IV
1.5
Q8
TAHBSO
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: